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Selective hyaluronan–CD44 signaling
promotes miRNA-21 expression and
interacts with vitamin D function
during cutaneous squamous cell
carcinomas progression following UV
irradiation
Lilly Y. W. Bourguignon* and Daniel Bikle
Endocrine Unit (111N2), Department of Medicine, San Francisco Veterans Affairs Medical Center, University of California at
San Francisco, San Francisco, CA, USA
Hyaluronan (HA), the major extracellular matrix component, is often anchored to CD44, a
family of structurally/functionally important cell surface receptors. Recent results indicate
that UV irradiation (UVR)-induced cutaneous squamous cell carcinomas (SCC) overex-
press a variety of CD44 variant isoforms (CD44v), with different CD44v isoforms appear to
confer malignant SCC properties. UVR also stimulates HA degradation in epidermal ker-
atinocytes. Both large HA polymers and their UVR-induced catabolic products (small HA)
selectively activate CD44-mediated cellular signaling in normal keratinocytes and SCC
cells, with all of the downstream processes being mediated by RhoGTPases (e.g., Rac1
and Rho). Importantly, we found that the hormonally active form of vitamin D 1,25(OH)2D3
not only prevents the UVR-induced small HA activation of abnormal keratinocyte behavior
and SCC progression, but also enhances large HA stimulation of normal keratinocyte
activities and epidermal function(s). The aim of this hypothesis and theory article is to
question whether matrix HA and its UVR-induced catabolic products (e.g., large and small
HA) can selectively activate CD44-mediated cellular signaling such as GTPase (Rac and
RhA) activation. We suggested that large HA–CD44 interaction promotes Rac-signaling
and normal keratinocyte differentiation (lipid synthesis), DNA repair, and keratinocyte
survival function. Conversely, small HA–CD44 interaction stimulates RhoA activation,
NFκB/Stat-3 signaling, and miR-21 production, resulting in inflammation and proliferation
as well as SCC progression. We also question whether vitamin D treatment displays any
effect on small HA–CD44v-mediated RhoA signaling, inflammation, and SCC progression,
as well as large HA–CD44-mediated differentiation, DNA repair, keratinocyte survival, and
normal keratinocyte function. In addition, we discussed that the topical application of
signaling perturbation agents (e.g., Y27623, a ROK inhibitor) may be used to treat certain
skin diseases displaying upregulation of keratinocyte proliferation such as psoriasis and
actinic keratoses in order to correct the imbalance between Rac and RhoA signaling
during various UV irradiation-induced skin diseases in patients. Finally, we proposed that
matrix HA/CD44-signaling strategies and matrix HA (HAS vs. HAL or HAS!HAL)-based
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therapeutic approaches (together with vitamin D) may be used for the treatment of
patients suffering a number of UV irradiation-induced skin diseases (e.g., inflammation,
skin cancer, and chronic non-healing wounds).
Keywords: hyaluronan, CD44, RhoGTPase, vitamin D, UVR, miR21, vitamin D, skin cancer
Introduction
The incidence of skin cancer has been increasing rapidly over
recent decades. UVB radiation (UVR)-induced squamous cell
carcinomas (SCC) is the second most common cancer among
Caucasians in the United States, contributing substantially to
morbidity among elderly people. Recent studies report that the
age-adjusted incidence of SCC has grown by 50–200% over the
past 10–30 years. Invasive SCC has the potential to recur locally,
tending to invade deeply into subcutaneous structures, fascia, and
muscle; and to metastasize, most commonly to regional lymph
nodes (1, 2). Several lines of evidence indicate thatmatrix hyaluro-
nan (HA) plays an important role in regulating inflammation, pro-
liferation, and migration/invasion in the progression of a variety
of tumors (3–7). Because little is known about the molecular basis
underlying HA effects on influencing skin cancer development,
there is currently a need to investigate some key aspects of HA
signaling in regulating UVR-induced human SCC progression.
Normal keratinocytes andhealthy skin tissues express predomi-
nantly one large species of the transmembrane glycoprotein, CD44
(Epican), required for many keratinocyte functions (3, 4). How-
ever, UVR-induced cutaneous SCC cells and tissues overexpress
a variety of variant isoforms of CD44 (3–9). Different CD44 vari-
ant (CD44v) isoforms appear to confer the malignant properties
of increased tumor cell growth and cancer progression (5–10).
CD44v isoforms bind a number of extracellular matrix (ECM)
ligands (e.g., HA), and are known to participate in a variety of
both normal keratinocyte and SCC functions (3–10). Our recent
results indicate that UVB stimulates HA degradation in normal
keratinocytes. Both large HA polymers and their smaller catabolic
products selectively activate CD44 isoform-mediated cellular sig-
naling that regulates inflammation, anti-apoptosis, and tumor cell
growth, as well as differentiation, DNA repair, and keratinocyte
survival function.
Skin Cancer
Recent studies report that the age-adjusted incidence of skin can-
cer has grown by 50–200% over the past 10–30 years. Exposure to
(UVR has well-recognized clinical effects on the skin, including
sunburn (inflammation) and keratinocyte transformation, lead-
ing to neoplasia and SCC progression. In particular, skin type
determines sensitivity to the acute and chronic effects of UVR on
the skin. Today, highly aggressive variants of SCC are frequently
seen in organ-transplant recipients, as well as in patients who
are on immunosuppressive medications or have immunocom-
promised status for other reasons (1, 2). Human papillomavirus
infection has also been associated with some types of cutaneous
SCC. Invasive SCC has the potential to recur locally, tending to
invade deeply into subcutaneous structures, fascia, and muscle;
and to metastasize, primarily to the regional lymph nodes (1, 2).
Because little is known about the molecular basis underlying the
progression to the invasive phenotype, it is very difficult to predict
individual tumor aggressiveness and design effective treatment
plans. Thus, there is currently a real need to clarify aspects of
tumor biology underlying the clinical behavior of SCC. It is well-
known that the tumor-specific phenotype (characteristics such
as inflammation, anti-apoptosis, and tumor cell proliferation)
is linked to oncogenic signaling. Dissection of the transmem-
brane pathways controlling cellular signaling and tumor functions
should significantly aid in understanding the intracellular events
underlying SCC progression.
Hyaluronan and CD44 in Normal Keratinocytes
and Squamous Cell Carcinomas
Hyaluronan, the major glycosaminoglycan of ECM component,
serves not only as a primary constituent of connective tissue
extracellular matrices but also as a bio-regulatory molecule (1,
2). Many studies indicate that HA is also abundant in strati-
fied squamous epithelia, including mammalian epidermis, and
that it influences epidermal functions such as skin integrity (10,
11). However, the mechanisms by which HA stimulates ker-
atinocyte functions and regulates tissue integrity are not well
understood. HA is synthesized by several HA synthases (12),
and its size further modified by hyaluronidases (13). Gener-
ally, small size-HA (1 105–1 104 Da) induces the expres-
sion of proinflammatory cytokine/chemokine and proliferative
genes as well as cell proliferation and migration; whereas large
size-HA (>1 106 Da) promotes transcriptional activation and
differentiation (14–20). UVR-induced changes in HA produc-
tion and degradation/fragmentation have also been reported
(19, 20). Specifically, while large HA appears to predomi-
nate in normal mouse skin, small HA becomes prevalent in
tumor tissues (19) and UVR-induced keratinocytes (20). All
of these observations are consistent with our hypothesis that
both HA production and HA size modifications underline
UVR-induced changes associated with onset of keratinocyte
transformation.
Both large and small HAs are capable of binding to CD44
(21), which is an ubiquitous, abundant, and functionally impor-
tant receptor expressed on the surface of many cells, including
normal and transformed keratinocytes (23). CD44 is encoded
by a single gene which contains 19 exons (22). The most com-
mon form, CD44s (CD44 standard form), contains exons 1–5
(N-terminal 150 a.a.), exons 15 and 16 (membrane proximal 85
a.a.), exon 17 (transmembrane domain), and a portion of exons
17 and 19 (cytoplasmic tail, 70 a.a.). Out of the 19 exons, 12
exons can be alternatively spliced. Most often, the alternative
splicing occurs between exons 5 and 15 leading to an inser-
tion in tandem of one or more variant exons (exon 6–exon 14;
v1–v10) within the membrane proximal region of the extra-
cellular domain (31). For example, in keratinocytes, additional
exons v3–v10 are inserted into the CD44s transcripts, and this
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isoform has been designated as CD44v3-10 (23). Various skin
cancer cells and tissues express different CD44 variant (CD44v)
isoforms (e.g., CD44v3 and CD44v10) in addition to CD44s and
CD44v3-10 (23). These CD44 isoforms have the same amino
acid sequences at the two ends of the molecule, but differ in
the middle region (v3–v10) within the CD44 membrane prox-
imal domain located at the external side of the membrane
(23). Several lines of evidence clearly indicate that CD44 selects
unique downstream effectors and coordinates certain down-
stream, intracellular signaling pathways that influence multiple
cellular functions (23).
Hypothesis
In this article, we described the hypothesis that HA and its UVR-
induced catabolic products (e.g., large and small HA) selectively
activate CD44-mediated Rac and RhoA signaling. Specifically,
large HA–CD44 interaction promotes Rac/PKNγ and p38MAPK-
dependent normal keratinocyte differentiation (lipid synthesis),
DNA repair, and keratinocyte survival function. Conversely,
small HA–CD44v isoform interaction stimulates RhoA/ROK-
dependent NFκB/Stat-3 signaling andmiR-21 production, result-
ing in inflammation and proliferation as well as SCC progres-
sion. Vitamin D treatment inhibits small HA–CD44v-mediated
RhoA/ROK signaling, inflammation, and SCC progression, and
it also enhances large HA–CD44-mediated differentiation, DNA
repair, keratinocyte survival, and normal keratinocyte function.
The results of this study will definitely provide a better under-
standing of the cellular and molecular mechanisms involved
in normal keratinocyte-mediated epidermal function and UVR-
induced human SCC progression, as well as vitamin D effects
on reducing UVR-induced keratinocyte transformation and skin
cancer.
Experimental Evidence
Detection of CD44v Isoform Expression in Normal
Keratinocytes, SCC Cells, and Skin SCC Tissues
Invasive SCC induced by UVR has the potential to recur locally,
tending to invade deeply into subcutaneous structures, fascia,
and muscle, and to metastasize, preferably to the regional lymph
nodes (1, 2). At the present time, very limited information is
available regarding the factors responsible for the onset and pro-
gression of skin SCC. One promising candidate in this regard is
the CD44 molecule. Our data using anti-CD44 antibody (recog-
nizing the common domain of all CD44 isoforms) confirm that
undifferentiated keratinocytes express various CD44 isoforms in
abundance (Figure 1-low calcium-treated sample). However, fol-
lowing high Ca2+-induced keratinocyte differentiation, the lower
molecular weight forms cease to be expressed leaving Epican as
the dominant species (Figure 1). CD44v isoforms are overex-
pressed in cutaneous SCC cell lines as compared to normal ker-
atinocytes (Figure 1). Furthermore, immunohistochemical stain-
ing using anti-CD44v3 antibody and anti-CD44v6 antibody con-
firms that both CD44v3 and CD44v6 isoforms are overexpressed
in human cutaneous SCC tissue (Figure 2). Only a very small
amount of CD44v isoforms is detected in normal skin tissue
(Figure 2). CD44v3 overexpression can also be detected in mouse
skin following chronic (to a lesser extent acute) UVB exposure
(Figure 2). These findings clearly indicate a strong correlation
between CD44v isoform expression and UVB-induced skin SCC
progression.
Anti-CD44 Immunoblot
M.W. x 10-3
Keratinocyte SquamousCell Carcinoma
Low   High   High
Ca2+ Ca2+  Ca2+  
24h     4h      24h    SCC-4   SCC-12  HACAT
Cell Lysates
CD44v3-10
CD44s
Epican (CD44v3-10)205-
150-
81-
52-
gp180/CD44v
FIGURE 1 | Detection of CD44 isoform expression in normal
keratinocytes and SCC cell lines using anti-CD44-mediated
immunoblotting techniques [SCC-4, SCC-12 cell lines, and HACAT (a
transformed cell line) Epican is designated as a CD44v3-10 form;
anti-CD44-mediated immunoblot was used to detect CD44 signal as
indicated].
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FIGURE 2 | (A) Immunoperoxidase staining of CD44v3 and CD44v6 isoforms in normal and SCC tissues of human skin; and (B) immunoperoxidase staining of
CD44v3 isoform in mouse skin following acute or chronic UVR exposure.
UVB-Induced Hyaluronan Fragmentation and
Abnormal Keratinocyte Functions
Hyaluronan belongs to one of the major glycosaminoglycan
polysaccharide families and plays an important role in the forma-
tion/remodeling of ECM, specifically in maintaining the integrity
of skin tissues (17, 18). Our data show that HA in normal
epidermis (without UVB treatment) exists as a large polymer
of approximately 1–2 106 Da molecular weight (“large HA”)
(Figure 3). These largeHApolymers are degraded into smallerHA
units (1 105–1 103 Da; “small HA”) following UVB treatment
(Figure 3).
Both large and small HAs are capable of binding to CD44 –
a ubiquitous, abundant, and functionally important receptor
expressed on the surface of many cells including normal ker-
atinocytes and SCC (Figure 2). Generally, small HA–CD44
interaction activates pro-inflammatory cytokine/chemokine gene
expression/production, proliferation, and migration, whereas
large HA–CD44 binding promotes certain transcriptional activa-
tion and differentiation (19, 20). HA–CD44 interaction induces
intracellular RhoGTPase (RhoA and Rac) signaling cascades
that regulate cytoskeletal reorganization and cell migration (18).
Whether HA/CD44 and RhoGTPase signaling actually cause
keratinocyte functions and SCC activation is not presently known,
and is addressed below.
HA/CD44-Mediated RhoA and Rac1 Signaling in
Cytoskeleton Activation and Keratinocyte and
SCC Functions
Members of the Rho subclass of the Ras superfamily [small molec-
ular weight GTPases (e.g., RhoA, Rac1, and Cdc42)] act as molec-
ular switches that alternate between GTP- and GDP-bound states.
The “activated” GTP-bound enzymes preferentially interact with
downstream effectormolecules thatmodulate other effector activ-
ities (24). For example, activation of RhoA and Rac1 signaling
has been shown to regulate cytoskeleton-associated functions in
normal and transformed keratinocytes (SCC cells) (19, 20).
RhoA-Activated Rho-Kinase Signaling Events
Previouswork indicated thatHA (mixed sizes) promotes the inter-
action betweenCD44 and several Rho-specific guanine nucleotide
exchange factors [e.g., p115RhoGEF (25) and LARG (26)], thereby
up-regulating RhoA (a member of the Rho subclass of the Ras
superfamily), leading to altered cytoskeleton-mediated cell func-
tions (25, 26). For example, activation of RhoA signaling has been
shown to be involved in cytoskeleton-associated functions. Several
enzymes have been identified as possible downstream targets for
RhoGTPases (e.g., RhoA) in regulating cytoskeleton-mediated
cell motility (27–38). One such enzyme is Rho-Kinase (ROK, also
called Rho-binding kinase), which is a serine–threonine kinase
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-UVB +UVB
Large HA
(1-2x106 Da)
Small HA
(~1x105 Da)
FIGURE 3 |Measurement of HA-size distribution in untreated mouse
epidermis vs. acute UVB-treated mouse epidermis. HA from untreated
mouse epidermis vs. acute UVB-treated mouse epidermis was isolated and
purified using gel filtration column chromatography, and then analyzed by an
enzyme-linked binding protein assay, that uses microwells coated with a
highly specific HA binding protein (HABP) to capture HA, and an
enzyme-conjugated HABP using a commercially available enzyme-linked
immunosorbent assay (ELISA)-type test kit. HA was also be analyzed by 0.5%
agarose gel followed by Alcian blue and silver staining.
(27–38). ROK interacts with RhoA in a GTP-dependent manner,
and phosphorylates a number of cellular substrates including
myosin light chain phosphatase, adducin, and LIM kinase (27–
38). HA–CD44 interaction promotes RhoA-ROK activation in
a number of tumor cells (27–38). Structurally, ROK is com-
posed of a catalytic (CAT), a coiled-coil, a Rho-binding (RB),
and a pleckstrin-homology (PH) domain (27–38). Overexpres-
sion of either the RB domain or the PH domains (dominant-
negative forms) of ROK by transfecting cells with RB cDNA or
PH cDNAblocksHA/CD44-specific phenotypic changes (27–38).
Also, inhibition of RhoA-activated ROK by Y27632 treatment
effectively blocks the HA/CD44-induced cellular signaling and
functions (31). These findings suggest that selective activation of
CD44 signaling (via small size- vs. large size-HA) induces differ-
ent RhoA–ROK pathway-specific effects in normal keratinocytes
and/or SCC.
Rac1-Activated PKNγ Signaling Events
HA (mixed sizes) also promotes the interaction between CD44
and several Rac1-specific guanine nucleotide exchange factors
[e.g., Tiam1 (32) and Vav2 (33)], thereby up-regulating Rac1
(another member of the Rho subclass of the Ras superfamily),
leading to altered cytoskeleton-mediated cell functions (32, 33).
Rac1 signaling has been shown to play an important role in
promoting epidermal stem cells to undergo self-renewal and
subsequent terminal differentiation (34). A number of enzymes
have been identified as possible downstream effectors for Rac1
signaling. One such enzyme is protein kinase N-γ (PKNγ) (also
called PRK2), which belongs to a family of serine–threonine
kinases known to interact with Rac1 in a GTP-dependent man-
ner. It also shares a great deal of sequence homology with
protein kinase C in the C-terminal region (35–38). The N-
terminal region of PKN contains three homologous sequences of
approximately 70 aa (relatively rich in charged residues), which
form an antiparallel coiled-coil fold (ACC domain) (35–38).
This ACC domain has been shown to interact with RhoGT-
Pases such as RhoA and Rac1 (and to a lesser extent with
Cdc42) (35–38). The C-terminal region contains the C2-like
region, which functions as an auto-inhibitory domain (35–
38). Both the ACC and the C2-like domains, together with
the catalytic domain, are conserved among the PKN family
members (35–38). In keratinocytes, RhoA-activated PKNγ has
been found to be involved in Fyn/Src kinase-regulated cell–cell
adhesion during Ca2+-induced differentiation (39). Our results
indicate that large HA specifically promotes CD44-mediated
Rac1-PKNγ kinase signaling (3) and the activation of down-
stream effectors, including p38MAPK, AP-1 protein (c-Jun), and
p63 (Figure 4). This pathway, in turn, regulates keratinocyte
differentiation.
Hyaluronan, CD44, and RhoGTPases in Normal
Keratinocytes and SCC
HA-mediated CD44 signaling has been shown to play an impor-
tant role in various cellular functions. Our preliminary data
indicate that small HA and large HA binding to cultured ker-
atinocytes and SCC-12 cells selectively activates RhoA and Rac1
(Table 1). In particular, small HA (but not large HA) pro-
motes RhoA signaling in cultured SCC-12 cells (to a lesser
extent normal keratinocytes) (Table 1). Further analyses indi-
cate that small HA-activated RhoA–ROK is capable of phos-
phorylating NFκB-p65 (Table 2), PKC" (Table 3), and Stat-3
(Table 3), leading to NFκB-specific (Table 2) and Stat-3-specific
transcriptional activation (Table 3), cytokine (IL-6)/chemokine
[monocyte-chemoattractant protein-1 (MCP-1)] gene expression
(Table 2), and cell proliferation (Table 2). The fact that the
ROK inhibitor, Y27632, significantly blocks small HA-induced
RhoA–ROK signaling and SCC functions (Tables 2 and 3) sug-
gests that small HA-mediated RhoA–ROK activation plays an
important role in regulating oncogenic signaling events and SCC
functions.
We also observed that the addition of large HA stimulates
Rac1 activation in normal keratinocytes and to a lesser extent
SCC (Table 1). In contrast, only a low level of Rac1 acti-
vation was detected in keratinocytes treated with small HA
or no HA (Table 1). These findings suggest that large HA
directly promotes Rac1 activation in normal keratinocytes. It
is noted that the level of p38MAPK phosphorylation and AP-
1 protein (c-Jun) phosphorylation is greatly enhanced in ker-
atinocytes treated with large HA (Figure 4). Transfection of
keratinocytes with PKNγ-ACCcDNA (but not vector-transfected
keratinocytes) (Figure 4) or treatment of keratinocytes with Vita-
min D not only inhibits large HA-mediated p38MAPK phospho-
rylation but also blocks AP-1 protein (c-Jun) phosphorylation
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FIGURE 4 | (A) Immunoblot analyses of large HA and PKN-dependent
phosphorylation of p38MAPK and AP-1 proteins (e.g., c-Jun) [the
PKN-dependent phosphorylation is proven by the effect of PKNγ-ACC cDNA
dominant negative mutant], and (B) immunoblot analyses of large HA and
vitamin D-induced c-Jun phosphorylation and differentiation marker (involucrin
and transglutaminase) expression in cultured keratinocytes.
in cultured keratinocytes (Figure 4). These results imply that
the ACC fragment of PKNγ (similar as Vitamin D) acts as a
dominant-negative mutant that downregulates large HA/CD44-
induced Rac1-PKNγ activation and p38MAPK/c-Jun signaling
required for normal keratinocyte functions. In addition, we have
found that large HA promotes the expression of differentia-
tion markers such as involucrin and transglutaminase in nor-
mal keratinocytes, and overexpression of PKNγ-ACC domain
(or treatment of Vitamin D) also blocks differentiation marker
expression as described previously (3). These findings sug-
gest that large HA-mediated Rac1-PKNγ plays an important
role in regulating p38MAPK-AP1 signaling and keratinocyte
differentiation.
Selective Small HA-Mediated CD44 Isoform
Signaling that Modulates Acute/Chronic
UVR-Induced Inflammation in SCC, and
Determine the Role of Large HA in Inhibiting
Small HA/CD44-Mediated Signaling and Thereby
Preventing UVR-Induced SCC Progression
There is compelling evidence that RhoA-activated ROK is
involved in the regulation of oncogenesis (18). UVR has acute
clinical effects on skin including inflammation. Pro-inflammatory
cytokines and chemokines such as IL-6, IL-1β, RANTES, and
MCP-1 contribute to inflammatory response in UVR-treated skin
(40, 41). Our results indicate that upregulation of cytokine (IL-6)
TABLE 1 | HA-induced RhoA and Rac1 activation in cultured keratinocytes
and SCC12 cells.
Samples [35S]GTPγRhoA (cpm)
(% of control)
[35S]GTPγRac1 (cpm)
(% of control)
Normal
keratinocytes
SCC-12
cells
Normal
keratinocytes
SCC-12
cells
No HA (control) 1002 1005 1003 1004
Small HA treatment 1555 32010 1532 1273
Large HA treatment 1133 1104 3138 1295
and chemokine (MCP-1) can be detected in mouse skin follow-
ing acute or chronic UVR exposure (Figure 5). These findings
clearly indicate a strong correlation between cytokine/chemokine
expression and UVR-induced skin cancer.
The transcription factor, NFκB, is known to regulate genes
involved in inflammatory responses (42). NFκB also controls cell
cycle regulatory genes such as cyclin D1 and promotes cellular
transformation (43, 44). Small HA (but not large HA)-mediated
CD44 isoform interaction has been shown to play an impor-
tant role in stimulating NFκB-inducing kinase (NIK). Activation
of the inhibitor of κB (IκB) kinase (IKK) complex (IKKα and
IKKβ) by NIK causes phosphorylation of the IκBs, targeting
them for ubiquitylation and degradation by proteasomes, which
liberate NFκB-p65 for nuclear translocation and transactivation
of a variety of pro-inflammatory gene expression (21). Small
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TABLE 2 | Small HA-mediated RhoA–ROK activation of NFκB-p65 and in cultured SCC-12 cells.
Samples NFκB-p65
phosphorylation
(% of control)
NFκB-p65-specific-
transcriptional activity
(% of control)
IL-6/MCP-1 gene expression
relative abundance (%)
Cell
proliferation
(% of control)
Untreated ROK (control) 1002 1002 0.740.03/0.630.01 1003
Large HA-treated RhoA-ROK 1043 1064 0.660.02/0.690.01 1055
Small HA-treated RhoA-ROK 31114 31513 3.080.10/2.880.05 30610
Small HA-treated RhoA-ROK+Y27632 1538 1203 0.600.03/0.650.04 1277
Small HA-treated RhoA-ROK+Vitamin D 1406 1345 0.630.02/0.670.03 1054
TABLE 3 | HA-mediated RhoA–ROK phosphorylation of PKC" and Stat-3 in cultured SCC-12 cells.
Samples PKC" phosphorylation
(mol of Pi/mol of protein)
Stat-3-Ser (727) phosphorylation
(% of control)
Stat-3-specific transcriptional
activity (% of control)
Unactivated ROK 0.1910.02 1002 1003
Large HA-activated RhoA–ROK 0.1930.03 1064 1045
Small HA-activated RhoA–ROK 1.2540.10 26510 27010
Small HA-activated RhoA–ROK+Y27632 0.1360.03 1247 1364
Small HA-treated RhoA–ROK+Vitamin D 0.1580.02 1358 1285
Chronic UVRAcute UVRNo UVR
IL-6 IL-6 IL-6
MCP-1 MCP-1 MCP-1
FIGURE 5 | Immunoperoxidase staining of cytokine (IL-6) and chemokine (MCP-1) in mouse skin following acute or chronic UVR exposure.
HA also stimulates NFκB, which controls proinflammatory genes
(e.g., IL-6, IL-1β, RANTES, or MCP-1 for inducing inflammatory
responses) and cell cycle regulatory genes (e.g., cyclinD1 or c-Myc
for activating cell proliferation) (42–44). A recent study indicates
that RhoA signaling plays a role in activatingNFκB signaling (45).
UVR is also known to promote PKC" overexpression (46)
and Stat-3 phosphorylation, leading to skin SCC development
(47). Our preliminary data indicate that small HA promotes
ROK phosphorylation of PKC" and Stat-3, which in turn stimu-
lates Stat-3-specific transcriptional activities (Figure 6; Table 3)
in SCC-12 cells. Large HA exerts direct anti-inflammatory and
anti-proliferation effects on UVR-induced skin cancers. Whether
large HA prevents small HA-mediated RhoA–ROK activation
and NFκB-p65 signaling, as well as PKC"-Stat-3 function in
transformed keratinocytes/SCC, and reverses small HA/CD44v-
mediated tumor-specific behaviors (e.g., pro-inflammatory gene
expression, cytokine/chemokine production, and proliferation) in
transformed keratinocytes and SCC will be investigated in the
future.
MicroRNA-21 (miR-21) Production and Vitamin D
1,25(OH)2D3 Effect on Mouse Skin Following
Acute and/or Chronic UVR Exposure
Dysregulation of microRNAs (miRNA) is observed in many can-
cers including skin cancer. In particular, miR-21 appears to play
an important role in tumor cell growth and SCC progression.
Mature miRNA (e.g., miR-21) are detected in UVB-treated cells
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Exon Exon miR-21
TGGTTCAAACCAGTTCTTACAGGAACTAGTGGTGATAAATGTGGGACTTCTGAGAAGTCATTCATTTTAT
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FIGURE 6 | (A) Illustration of 130-bp regions containing two predicted Stat-3
binding sites (site 1 and site 2) upstream of the miR-21 genes; (B) ChIP assay
of SCC-12 cells treated with no HA (lane 1) or with small HA (lane 2) using
anti-PKC", anti-Stat-3, or IgG control. Co-immunoprecipitated DNA was
amplified by PCR with primers specific for the miR-21 upstream promoter
enhancer.
and skin carcinogenesis. In this study, we investigated the regu-
lation and expression of miR-21 in mouse skin following acute
and/or chronic UVR exposure as described below:
Identify HA/CD44-Mediated PKC"-Stat-3-Specific
Target Genes
The mechanism of cellular transformation in keratinocytes and
SCC is likely to be the results of several genes that are tran-
scriptionally controlled by the PKC"-Stat-3 interaction. Previous
studies indicate that activated Stat-3 up-regulates themRNA levels
of many genes, including miR-21. The expression of mature miR-
21 is detected in various SCC cell lines and patient specimens.
Many studies indicate that miR-21 may function as an oncogene
and play a role in anti-apoptosis and tumorigenesis. A recent study
indicates that the gene encoding oncogenic miR-21 is regulated
by an upstream promoter/enhancer containing two Stat-3 binding
sites (as diagramed in Figure 6). In order to investigate whether
HA–CD44-induced PKC"-Stat-3 complex is involved in the regu-
lation of miR-21 expression in normal/transformed human ker-
atinocytes (SCC 12F2 and SCC12B2) or UVB-treated murine
keratinocytes (from epidermal sheets), we conducted chromatin
immunoprecipitation (ChIP) reporter gene assays as described
below.
Chromatin Immunoprecipitation Assays
To examine whether the PKC"-Stat-3 complex directly inter-
acts with the upstream promoter/enhancer region of miR-21,
1 2 3 4 5 6
a: miR-21
b: miR-191
(loading control)
FIGURE 7 | UVB-induced miR-21 production using RNase protection
assay in cultured keratinocytes [treated with no UVB (lane 1) or with
UVB (lane 2) or treated with ROK inhibitor (Y27632) plus UVB (lane 3)
or treated with UVB and vitamin D (lane 4)], and in UVB-induced SCC
tumor tissues (lane 5) or normal skin tissues (lane 6).
ChIP assays were performed in normal/transformed human ker-
atinocytes (SCC12F2 and SCC12B2) or UVB-treated murine ker-
atinocytes (from epidermal sheets) in the presence or absence of
small/large HA (50µg/ml) for 2 h at 37°C using a kit (EZ ChIP)
fromMillipore Corp., according to themanufacture’s instructions.
Cross-linked chromatin lysates were sonicated and diluted with
ChIP sonication buffer plus protease inhibitors, divided, and incu-
batedwith normal rabbit IgG or rabbit anti-PKC" antibody or rab-
bit anti-Stat-3 antibody at 4°C overnight, then precipitated with
protein G-agarose. Cross-linking will be reversed by overnight
65°C incubation; DNA fragments then will be extracted with
PCR purification kit, analyzed by PCR, and quantitated by real-
time PCR using primer pair specific for the miR-21 upstream
promoter/enhancer region containing the Stat-3 binding sites: for-
ward primer: 50-CTGGGAGAAACCAAGAGCTG-30 and reverse
primer:AGGGGACAAGTCAGAGAGAGG-30 on an agarose gel
as described previously (48). Results from these proposed exper-
iments will allow us to verify the direct involvement of PKC"
and/or Stat-3 in regulating the expression of specific target genes
such as miR-21 in UVB-treated normal and transformed ker-
atinocytes. Preliminary data indicate that PKC" and Stat-3 are
recruited to the miR-21 upstream promoter enhancer region in
SCC-12 cells treated with small HA (Figure 6).
Effect of MicroRNA-21 (miR-21) Production on Mouse
Skin Following Acute and/or Chronic UVR Exposure
Our results using RNase protection assays (Figure 7) show that
the level of miR-21 production is significantly elevated in cultured
keratinocytes treated with UVB (Figure 7, lane 2) as compared
to those cells without UVB treatment (Figure 7, lane 1). The
expression of Programed Cell Death 4 (PDCD4) gene is strongly
induced during apoptosis in a number of cell types (49–51).
PDCD4 encodes a tumor suppressor protein whose expression
is lost in progressed carcinomas of many solid tumors (49–51).
PDCD4 has been identified as one of the tumor suppressor genes
regulated by miR-21 (48, 52, 53). It inhibits translation of PDCD4
by forming a complex with the translation initiation factor eIF4A
(an RNA helicase) (54–56).
The “inhibitors of apoptosis family of proteins” (IAPs) con-
stitute a family of at least nine proteins including survivin that
block apoptosis by direct binding to caspases (57). Overexpression
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of IAPs (e.g., survivin) is thought to be linked to chemoresis-
tance by suppressing apoptosis (57, 58). Our data indicate that
HA–CD44-mediated Stat-3 activation induces up-regulation of
survival proteins (surviving) expression leading to anti-apoptosis
and multidrug resistance in epithelial tumor cells. The fact that
downregulation of either PKC" or Stat-3 by treating SCC-12 cells
with PKC" siRNA or Stat-3 siRNA blocks HA/CD44-mediated
cyclin D1/survivin expression suggests that both PKC" and Stat-3
play important roles in the expression of all these proteins.
Vitamin D 1,25(OH)2D3 Effect on Mouse Skin
Following Acute and/or Chronic UVR Exposure
Vitamin D 1,25(OH)2D3 and its analogs exert direct anti-
inflammatory and anti-proliferation effects on UVR-induced skin
cancers (59–62). A previous study indicated that one of the hor-
monally active vitamin D analogs (BXL-628) inhibits ROK mem-
brane localization and activation in tumor cells (63). Recently,
a study also indicates that vitamin D [via vitamin D receptor
(VDR) action] was shown to abrogate the ability of NFκB-p65 to
transactivate gene transcription and to block cytokine/chemokine
gene expression as well as subsequent inflammatory responses
and drug resistance in epithelial cells (64, 65). Our data indi-
cate that 1,25(OH)2D3 (similar as large HA) (65) prevents small
HA-mediated RhoA–ROK activation and NFκB-p65 signaling, as
well as PKC"-Stat-3 function in transformed keratinocytes/SCC,
and reverses small HA/CD44v-mediated tumor-specific behav-
iors (e.g., pro-inflammatory gene expression, cytokine/chemokine
production, and proliferation) in transformed keratinocytes and
SCC (Tables 2 and 3).
In addition, we found that cultured keratinocytes treated with
either ROK inhibitor (Y27632) (Figure 7, lane 3) or vitamin
D (Figure 7, lane 4) or normal skin tissues (Figure 7, lane 6)
contain significantly less UVB-induced miR-21 [as compared
with UVB-induced SCC tumor tissues (Figure 7, lane 5)]. The
expression of miR-21 occurs in SCC tumor tissues (Figure 8) (but
not in normal skin tissues) (Figure 8). Using digoxigenin (DIG)-
labeled miR-21 probe (LNA probe) (and scrambled probe) and
in situ hybridization [incubated with an anti-DIG-AP (alkaline
phosphatase)-FAB fragment plus NBT/BCIP], we have detected
an upregulation of miR-21 in VDR-null mouse skin (to a lesser
extent wild-type mouse skin) following chronic UVR exposure.
In contrast, very little miR-21 is detected in either VDR-null mice
or wild-type mice following acute UVR or no UVR treatment
(Figure 8). These findings suggest that VDR has a protective
role to attenuate miR-21 production, and downregulation of VDR
enhances miR-21 expression leading to tumor cell growth and
skin SCC progression. These observations strongly suggest that
UVB promotes miR-21 production in both cultured keratinocytes
and SCC tumors. Our observations also support our hypothesis
that vitamin D (together with ROK inhibition) may serve as a
protective agent to impair UVB-induced miR-21 production and
skin cancer progression.
Determine How Large HA/CD44 Epican
Interactions with Rac1-Activated PKNγ Lead to
Modulations in Epidermal Functions, DNA Repair,
and Keratinocyte Survival in Mouse Epidermis
Following Acute or Chronic UVR-Induced Skin
Cancer Development
A previous study showed that HA/CD44-mediated Rac1-PKNγ
activation plays an important role in regulating keratinocyte
differentiation (8). Our recent work indicates that large HA
(but not small HA) stimulates keratinocye signaling (Figure 4).
The question of how large HA/CD44-induced Rac1-PKNγ
signaling pathway mediates keratinocyte differentiation is not
well-understood. In mammalian cells, at least three distinct
Chronic UVB
VDR -/-
Acute UVBNo UVB
VDR +/+ VDR +/+ VDR +/+
VDR -/- VDR -/-
A B C
D E F
a
b
FIGURE 8 | Detection of UVB-induced miR-21 expression in wild-type (VDR+/+) and VDR-null (VDR / ) mouse skin using DIG-labeled miR-21 probe
(LNA probe) (A–F) (and scrambled probe) (a & b) and in situ hybridization [incubated with an anti-DIG-AP (alkaline phosphatase)-FAB fragment plus
NBT/BCIP].
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mitogen-activated kinases (MAPKs) [e.g., ERKs (extracellular
signal regulated kinases), the stress-responsive JNK/SAPKs, and
p38MAP kinases (p38MAPK)] have been characterized (66, 67).
There is compelling evidence that activation of p38MAPK occurs
in themembrane (68, 69). Activated p38MAPKhas been shown to
phosphorylate specific transcription factors and proteins includ-
ing the transcription factor activator proteins (AP-1) (consisting
of members of Jun family of nuclear proteins such as c-Jun, JunB,
JunD, Fra-1, Fra-2, c-Fos, and FosB) (70–74). Subsequently, phos-
phorylatedAP-1 proteins bind toDNA elements and induce target
gene expression (72, 73). In keratinocytes, the promoter activity
of several differentiation-related markers (e.g., involucrin and
transglutaminase) and cholesterol synthesis-related proteins (e.g.,
HMG-CoA synthase and HMG-CoA reductase). Both cholesterol
synthesis-related proteins (e.g., HMG-CoA synthase and HMG-
CoA reductase) known to be involved in keratinocyte lipid syn-
thesis and differentiation appear to be closely associated with
p38MAPK and AP-1 phosphorylation (activated forms) (71–73).
Our data indicate that large HA stimulates p38MAPK and c-Jun
phosphorylation (Figure 4) as well as keratinocyte differentiation
(Figure 4).
UV-induced DNA lesions are known to be repaired by
nucleotide excision repair (NER) (74), which operates via either
global genomic repair (GGR) or transcription-coupled repair
(TCR) (75, 76). Loss of certain NER proteins such as xeroderma
pigmentosum group C (XPC) results in a selective impairment of
GGR (75, 76). The p38MAPK appears to be involved in activating
p53 and p63 – both of which are key regulators of NER (75–80)
and have been shown to play an important role in maintenance
and induction of VDR and certain key DNA damage recog-
nition proteins (e.g., XPC). Whether large HA/CD44-activated
Rac1-PKNγ and p38MAPK are involved in regulating p63/p53
signaling leading to DNA repair and keratinocyte survival follow-
ing UVR exposure is investigated in this study. Our results indi-
cate that pretreatment of cultured keratinocytes with exogenously
added large HA exhibited a 1.7-fold enhancement of cell survival
(P< 0.0004) following UVB 708 (J/m2) treatment.
These findings reveal selective activation of Rac1-PKN activa-
tion by large HA with pathway-specific effects on normal ker-
atinocyte functions. In particular, we have discovered a novel sig-
naling mechanism showing large HA stimulation of Rac1-PKNγ1
and phosphorylation of p38MAPK in cultured keratinocytes. It is
possible that Rac1-PKNγ1 phosphorylated p38MAPK promotes
AP-1 (c-Jun) (Figure 4) and p63/p53-mediated transcriptional
upregulation (Figure 9), resulting in target gene expression and
epidermal functions. We have found that the protein level of
certain regulatory molecules such as p38MAPK, p63, VDR, and
XPC is greatly enhanced in both cultured keratinocytes/epidermal
sheets treated with large HA (but not small HA) (Figure 9). In
contrast, the expression level of these key regulatory proteins (e.g.,
p38MAPK, p63, XPC, or VDR) is relatively low in keratinocytes
treated with HA or p38MAPK inhibitor (anti-CD44 antibody and
SB203580, respectively) plus large HA (Figure 9). These findings
suggest that large HA/PKN-induced p38MAPK signaling plays an
important role in both maintenance and induction of tumor sup-
pressor proteins (e.g., p63) and VDR as well as certain key DNA
damage recognition proteins (e.g., XPC). These findings support
the notion that large HA/CD44 signaling events may interact with
DNA repair pathways required for epidermal protection against
UVB-induced skin damage.
In summary, we would like to propose the following model
(Figure 10): UVR induced HA degradation and selective HA
(small HA vs. large HA)-CD44 interaction with RhoA–ROK and
Rac1-PKNγ in regulating transformed and normal keratinocyte
d: Anti-XPC
a: Anti-p38MAPK
b: Anti-p63
c: Anti-VDR
e: Anti-Actin
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FIGURE 9 | Large HA-mediated upregulation of signaling regulators in
keratinocytes. Murine keratinocytes isolated from epidermal sheets were
pretreated with HA (50µg/ml) (lane 2) in the presence or absence of p38MAPK
inhibitor (SB203580) for 24 h followed by irradiation with UVB (708 J/m2),
harvested and analyzed by immunoblotting using anti-p38MAPK (a) or anti-p63
antibody (b) or anti-VDR antibody (c) or anti-XPC antibody (d) respectively.
Actin was probed by anti-actin antibody as a loading control. (Cells were treated
with no HA (lane 1) or with large HA (lane 20) or with anti-CD44 plus large HA
(lane 3) or with SB203580 plus large HA (lane 4) or with small HA (lane 5) [p63, a
p53-like transcription factor; VDR, vitamin D receptor; XPC, DNA repair protein].
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FIGURE 10 | A proposed model for UVR-induced hyaluronan (HA)
degradation and selective HA (small HA vs. large HA)-CD44 interaction with
RhoA–ROK and Rac1-PKNγ in regulating normal and transformed keratinocyte
signaling leading to healthy epidermal function and/or cutaneous squamous cell
carcinomas (SCC) progression. Vitamin D enhances large HA-CD44-mediated
differentiation, DNA r8epair, and keratinocyte survival/normal epidermal function,
and it also inhibits small HA/CD44v-mediated RhoA–ROK signaling and
SCC-specific tumor behaviors.
signaling leading to cutaneous SCC progression and/or healthy
epidermal function. Vitamin D enhances large HA-CD44-
mediated differentiation, DNA repair, and keratinocyte sur-
vival/normal epidermal function, and it also inhibits small
HA/CD44v-mediated RhoA–ROK signaling and SCC-specific
tumor behaviors.
Summary and Outlook
To test our hypothesis, we provided new experimental evi-
dence showing that administration of large HA or vitamin
D-related treatments can selectively downregulate the CD44-
RhoA/ROK-mediated inflammatory pathways and upregulate
CD44-Rac/PKNγ-mediated cell differentiation, DNA repair, and
keratinocyte survival function in mouse skin exposed to acute or
chronic UVR. The ability for us to identify key HA (small vs.
large HA)/CD44-mediated Rho/Rac signaling mechanism(s) by
acute or chronic UVR in the regulation of keratincocyte functions
will provide valuble insights regarding the possible HA/CD44
involvement of acute or chronic UVR-induced changes in influ-
encing abnormal keratinocyte function, epidermal dysfunction,
and tumor formation/SCC progression. In addition, we suggested
that signaling perturbation agents (e.g., Y27623, a ROK inhibitor)
can be applied to acute or chronic UVR-induced tumor for-
mation/SCC progression displaying upregulation of keratinocyte
inflammation and proliferation in order to correct the imbalance
between RhoA–ROK signaling and Rac1-PKNγ activation during
epidermal dysfunction.
In conclusion, we believe that the information obtained from
these studies described in this article will allow us to delin-
eate UVR-induced HA (small vs. large HA)-mediated CD44 sig-
naling mechanisms and subsequent keratinocyte activities, as
well as to provide important HA-based and vitamin D-related
therapeutic approach regarding the treatment of UVR-induced
keratinocyte transformation and skin cancer progression. The
overall idea here is to develop innovative approaches to affect
skin cancer growth and SCC progression that may be useful for
future clinical studies. The new knowledge obtained from our
HA/CD44-signaling strategies and HA-based/vitamin D thera-
peutic approaches should reveal new avenues for possible treat-
ment of UVR-induced skin cancers.
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